Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 2000
  • Start Date: July 2022
Safety and Efficacy of One Month Dual Antiplatelet Therapy Versus Standard Therapy With Oral Anticoagulant Plus P2Y12 Inhibitor and Short Course of Aspirin in Patients With Acute Coronary Syndrome or Percutaneous Coronary Intervention and Atrial Fibrillation: an Open-label, Multicentre, Randomised Controlled Trial.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: January 25, 2022
Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery (MINA)
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 120
  • Start Date: January 1, 2022
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation (ICM REDUCE-AF)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Diagnostic Test
  • Participants: 1368
  • Start Date: January 1, 2022
D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 2000
  • Start Date: January 2022
INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 30
  • Start Date: November 30, 2021
Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for Atrial Fibrillation
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: October 2021
Semaglutide for the Reduction of Arrhythmia Burden in Overweight and Obese Patients With Atrial Fibrillation (Pilot Study)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 6090
  • Start Date: October 1, 2021
Effectiveness of Echocardiographic Screening of Pregnant Women During Antenatal Care: a Cluster Randomized Crossover Trial
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device, Other
  • Participants: 477
  • Start Date: October 1, 2021
Confirm Rx Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High Risk Heart Failure Patients
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 590
  • Start Date: October 1, 2021
AntiCoagulation Tracking InterVention and Evaluation: Using a Customized Panel Management Platform to Improve Outcomes for Patients on Anticoagulation
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 50
  • Start Date: September 20, 2021
Outcomes of High Power Application in Catheter Ablation of Paroxysmal Atrial Fibrillation Guided by Unipolar Signal Modification.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Device, Procedure
  • Participants: 77
  • Start Date: September 1, 2021
Personalized Atrial Fibrillation Ablation With the QDOT Catheter - The QDOT-by-LAW Trial
Showing 1-12 of 929